Lung Cancer Surgery Market to Exceed $20.2 Bn by 2031 Amid Rising Incidence of Lung Cancer – TMR Insights
The global Lung Cancer Surgery Market, valued at US$ 12.3 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 5.6% from 2023 to 2031, reaching an estimated valuation of US$ 20.2 billion by the end of the forecast period. The growing adoption of personalized medicine and the introduction of cutting-edge cancer therapies, such as immunotherapy, are expected to further contribute to the development of the market
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32156
Market Overview
Lung cancer remains one of the most prevalent and deadly cancers worldwide, driving the demand for advanced surgical interventions. The increasing incidence of lung cancer, advancements in minimally invasive surgical techniques, and rising awareness about early detection are fueling market expansion.
“Technological innovations in robotic-assisted surgery and video-assisted thoracoscopic surgery (VATS) are transforming lung cancer treatment, improving patient outcomes while reducing recovery time,” said TMR Research.
Key Market Trends and Drivers
Several factors are contributing to the steady growth of the lung cancer surgery market:
- Rising Global Lung Cancer Cases – Increasing smoking rates, air pollution, and occupational hazards contribute to the growing burden of lung cancer.
- Advancements in Minimally Invasive Surgeries – Techniques like robotic-assisted thoracic surgery and VATS are enhancing precision and reducing post-operative complications.
- Growing Adoption of Personalized Medicine – The integration of molecular diagnostics is helping tailor surgical approaches for improved treatment efficacy.
- Supportive Government Initiatives – Public awareness campaigns and funding for cancer research are driving early diagnosis and treatment adoption.
- Expansion of Healthcare Infrastructure in Emerging Markets – Growing investment in healthcare facilities across Asia-Pacific and Latin America is increasing access to lung cancer surgeries.
Recent Developments
- Intuitive Surgical (2023) – Launched an advanced robotic-assisted thoracic surgery platform, enhancing precision in lung cancer surgeries.
- Johnson & Johnson (2023) – Expanded its minimally invasive lung surgery portfolio with AI-driven surgical navigation technologies.
- Medtronic (2023) – Received regulatory approval for a next-generation thoracoscopic surgical system aimed at improving patient outcomes.
Competitive Landscape
The lung cancer surgery market is highly competitive, with major players focusing on R&D investments, technological innovations, and strategic collaborations. Leading companies include:
- Medtronic
- Siemens Healthineers
- Accuray Incorporated
- KARL STORZ
- Olympus Corporation
- Intuitive Surgical
- Ethicon (Johnson & Johnson Services, Inc.)
To Know More About Report - https://www.transparencymarketresearch.com/lung-cancer-surgery-market.html
Analyst Viewpoint
The rising incidence of lung cancer globally is driving the demand for surgical interventions. According to the World Health Organization (WHO), approximately 2.21 million lung cancer cases were reported worldwide in 2020. Advances in surgical technologies, particularly minimally invasive techniques, are making lung cancer surgeries safer, more efficient, and less traumatic for patients. This has led to increased demand for early-stage surgical interventions, which are most effective in improving patient outcomes, thereby fueling the growth of the global lung cancer surgery market.
Additionally, the growing adoption of personalized medicine and the introduction of cutting-edge cancer therapies, such as immunotherapy, are expected to further contribute to the development of the lung cancer surgery market. These innovations are enhancing treatment efficacy and expanding the scope of surgical options, creating new opportunities for market growth.
Future Outlook
With continuous advancements in surgical technologies, increasing awareness about early lung cancer detection, and rising regulatory approvals, the lung cancer surgery market is set for sustained growth. The integration of AI, robotics, and real-time imaging in surgical procedures will further revolutionize lung cancer treatment.
“As healthcare technology continues to evolve, lung cancer surgeries will become more precise and less invasive, ultimately improving patient survival rates.
Market Segmentation
The lung cancer surgery market is segmented based on procedure type, surgical approach, and end user:
- By Procedure Type: Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection
- By Surgical Approach: Open Surgery, Minimally Invasive Surgery (VATS, Robotic-Assisted Surgery)
- By End User: Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32156
By Region
- North America leads the market due to high lung cancer prevalence, strong healthcare infrastructure, and widespread adoption of advanced surgical technologies.
- Europe holds a significant share, driven by increasing government initiatives for early lung cancer detection and treatment.
- Asia-Pacific is expected to witness the fastest growth due to rising healthcare investments, growing awareness about lung cancer, and an expanding patient pool.
Explore Latest Research Reports by Transparency Market Research:
Dental Composites Market (Markt für Dentalkomposite) Projected to grow at a CAGR of 8.6% from 2024 to 2034 and reach US$ 171.3 Mn by the end of 2034.
Lyophilization Equipment and Services Market (Markt für Gefriertrocknungsgeräte und -dienstleistungen) Estimated to grow at a CAGR of 7.7% from 2024 to 2034 and reach more than US$ 13,478.1 Mn by the end of 2034.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Follow Us: LinkedIn| Twitter| Blog | YouTube

Editor Details
-
Company:
- Transparency Market Research
-
Name:
- Rahul Mengane
- Email:
-
Telephone:
- +448455651771
- Website:
Related Links
- Website: Lung Cancer Surgery Market